Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Evista
| Field | Information |
|---|---|
| Medication Name | Evista |
| Generic Name | Raloxifene |
| Boxed/Label Warning | Increased risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. |
| Purpose | Prevention and treatment of osteoporosis in postmenopausal women; reduces the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer. |
| Mechanism of Action | Selective estrogen receptor modulator (SERM); acts as an estrogen agonist in bone and an estrogen antagonist in breast and uterine tissue. |
| Dosage Forms | Oral tablets |
| Available Strengths | 60 mg |
| Dosage Frequency | Once daily |
| Common Side Effects | Hot flashes, leg cramps, swelling, arthralgia (joint pain) |
| Serious Side Effects | Deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, retinal vein occlusion, increased risk of death due to stroke in women with coronary heart disease or at increased risk for coronary events. |
| Drug Interactions | Warfarin, other estrogens, cholestyramine |
| Important Notes | Not for use in premenopausal women or men. Discontinue at least 72 hours prior to and during prolonged immobilization (e.g., post-surgery, prolonged bed rest). Ensure adequate calcium and vitamin D intake. |
| Storage | Store at room temperature away from moisture and light. |
| Missed Dose | Take as soon as you remember unless it is almost time for your next dose. Do not double the dose. |
| Alternatives | Fosamax (alendronate), Actonel (risedronate), Boniva (ibandronate), Prolia (denosumab), Aclasta (zoledronic acid) |
Evista Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Fosamax (alendronate) | Bisphosphonate; inhibits osteoclast-mediated bone resorption. | First-line treatment for osteoporosis. Available generically. |
| Actonel (risedronate) | Bisphosphonate; inhibits osteoclast-mediated bone resorption. | Available in daily, weekly, and monthly formulations. |
| Boniva (ibandronate) | Bisphosphonate; inhibits osteoclast-mediated bone resorption. | Available in monthly oral and quarterly intravenous formulations. |
| Prolia (denosumab) | RANKL inhibitor; inhibits osteoclast formation, function, and survival. | Administered as a subcutaneous injection every six months. |
| Aclasta (zoledronic acid) | Bisphosphonate; inhibits osteoclast-mediated bone resorption. | Administered as an intravenous infusion once a year. |
Evista Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Hot flashes | Deep vein thrombosis (DVT) |
| Leg cramps | Pulmonary embolism (PE) |
| Swelling | Stroke |
| Arthralgia (joint pain) | Retinal vein occlusion |
| Sinusitis | Increased risk of death due to stroke (in women with coronary heart disease or at increased risk for coronary events) |
Evista Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Osteoporosis Prevention | 60 mg | 60 mg once daily | May be taken with or without food. |
| Osteoporosis Treatment | 60 mg | 60 mg once daily | May be taken with or without food. |
| Breast Cancer Risk Reduction | 60 mg | 60 mg once daily | May be taken with or without food. |
Evista Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $50 |
| Without Insurance (U.S.) | $200 – $260 |
| From CPS | $41.41 |
